Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells

scientific article

Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11234890

P2093author name stringNguyen D
Bhalla K
Nimmanapalli R
O'Bryan E
Perkins C
Porosnicu M
Worthington E
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectleukemiaQ29496
acute leukemiaQ976388
apoptotic processQ14599311
P304page(s)350-357
P577publication date2001-02-01
P1433published inClinical Cancer ResearchQ332253
P1476titleCotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells
P478volume7